Business Daily Media

Business Marketing

.

Eisai: Dayvigo (Lemborexant) Approved for Treatment of Insomnia in Japan

  • Written by ACN Newswire - Press Releases

image

TOKYO, Jan 23, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGO (2.5mg, 5mg, and 10mg tablets, lemborexant) for treatment of insomnia.

DAYVIGO is a dual orexin receptor antagonist that inhibits orexin

Read more //?#

Popular

Creating my own space in the start-up tech industry

When I ventured out to launch a start-up targeting mums, I knew it wasn’t going to be easy. In a field that is heavily male-dominated, the gender funding gap is ever-present, with some suggesting the issue stems from bias that i...

Inclusive Competitiveness: Key to Future U.S. Economic Prosperity

Former NFL Player’s Book Says Inclusive Competitiveness is Key to Future U.S. Economic Prosperity  Some may only know Johnathan Holifield as a former Cincinnati Bengals running back, but since his stint in the NFL, he’s been ...

8 Web Design Trends You Should Follow in 2021

If you have been running a website for a while now, then you probably know how web design can make or break your business. To look like this: If you have been running a website for a while now, then you probably know how web ...